TickerFacts.

BioCorRx Inc. (BICX): Gross Profit

Annual figures by period end, from SEC filings. For years the company left out, it is revenue minus cost of revenue, computed by TickerFacts; where both exist they agree (see each figure's source).

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$6.0K
Year ended 2024-12-31
-47.9%
3-year compound annual growth
-48.1%
5-year compound annual growth
-39.7%
10-year compound annual growth
$950.0K2010-12-31: -$11.8K2011-12-31: $371.3K2012-12-31: $465.7K2013-12-31: $554.8K2014-12-31: $950.0K2015-12-31: $772.8K2016-12-31: $526.3K2017-12-31: $333.7K2018-12-31: $205.7K2019-12-31: $158.6K2020-12-31: $26.7K2021-12-31: $42.4K2022-12-31: $198.6K2023-12-31: $53.2K2024-12-31: $6.0K$6.0K
2010-12-31 Gross Profit (USD) 2024-12-31
Period endedGross ProfitChange YoYSource filing
2024-12-31$6.0K-88.7%2026-03-31, From 2024-01-01
2023-12-31$53.2K-73.2%2025-03-31, From 2023-01-01
2022-12-31$198.6K+368.4%2024-04-01, From 2022-01-01
2021-12-31$42.4K+58.9%2023-03-31, From 2021-01-01
2020-12-31$26.7K-83.2%2022-03-31, From 2020-01-01
2019-12-31$158.6K-22.9%2021-03-31, From 2019-01-01
2018-12-31$205.7K-38.4%2020-03-30, From 2018-01-01
2017-12-31$333.7K-36.6%2019-04-16, From 2017-01-01
2016-12-31$526.3K-31.9%2018-04-05, From 2016-01-01
2015-12-31$772.8K-18.7%2017-04-13, From 2015-01-01
2014-12-31$950.0K+71.2%2016-04-14, From 2014-01-01
2013-12-31$554.8K+19.1%2014-04-14, From 2013-01-01
2012-12-31$465.7K+25.4%2014-04-14, From 2012-01-01
2011-12-31$371.3Kn/m2013-04-15, From 2011-01-01
2010-12-31-$11.8Kn/a2012-05-18, From 2010-01-01